BackMeribank Biotech , Ltd Overview

Meribank Biotech , Ltd Current Assets

Meribank Biotech , Ltd's current assets is $430M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$426.10M
↑ 19.71% YoYΔ $70.16M vs prior year quarter

Peer trimmed avg / median

Loading

Meribank Biotech , Ltd Current Assets History

Loading

Meribank Biotech , Ltd vs. peers: Current Assets Comparison

Loading

Meribank Biotech , Ltd Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Meribank Biotech , Ltd (4724.TWO) FAQ

As of the most recent data (June 2026), 4724.TWO shows a current assets of $430M. That compares with $360M in the prior-year period — up 19.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4724.TWO's current assets is now $430M (was $360M) — a 19.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Meribank Biotech , Ltd is outperforming or lagging.

Tracking 4724.TWO's current assets over time shows whether Meribank Biotech , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $430M That compares with $360M in the prior-year period — up 19.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Meribank Biotech , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $430M) with ownership activity and broader fundamentals.

Meribank Biotech , Ltd's current assets is $430M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.